These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1575022)

  • 21. Case report: acute hydrops and spontaneous corneal perforation in a patient with keratoconus treated with colchicine for familial Mediterranean fever.
    Hilely A; Kleinmann G
    Int Ophthalmol; 2019 Jun; 39(6):1367-1369. PubMed ID: 29713855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Familial Mediterranean fever].
    Georgin-Lavialle S; Hentgen V; Stankovic Stojanovic K; Bachmeyer C; Rodrigues F; Savey L; Abbara S; Conan PL; Fraisse T; Delplanque M; Rouet A; Sbeih N; Koné-Paut I; Grateau G
    Rev Med Interne; 2018 Apr; 39(4):240-255. PubMed ID: 29526329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fertility and obstetric history in patients with familial Mediterranean fever on long-term colchicine therapy.
    Ehrenfeld M; Brzezinski A; Levy M; Eliakim M
    Br J Obstet Gynaecol; 1987 Dec; 94(12):1186-91. PubMed ID: 3426990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of amyloidosis in familial Mediterranean fever with colchicine: a case-control study in Armenia.
    Sevoyan MK; Sarkisian TF; Beglaryan AA; Shahsuvaryan GR; Armenian HK
    Med Princ Pract; 2009; 18(6):441-6. PubMed ID: 19797919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy and complicated familial Mediterranean fever.
    Shimoni Y; Shalev E
    Int J Gynaecol Obstet; 1990 Oct; 33(2):165-9. PubMed ID: 1976551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy outcome of five patients with renal amyloidosis regarding familial Mediterranean fever.
    Turgal M; Selcuk I; Ozyuncu O
    Ren Fail; 2014 Mar; 36(2):306-8. PubMed ID: 24168456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Systemic AA amyloidosis caused by familial Mediterranean fever and response to colchicine].
    Fukui N; Mukoyama M; Saito Y; Mori K; Kasahara M; Yokoi H; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Nihon Naika Gakkai Zasshi; 2008 Dec; 97(12):3046-8. PubMed ID: 19209520
    [No Abstract]   [Full Text] [Related]  

  • 28. Familial Mediterranean Fever.
    Kucuk A; Gezer IA; Ucar R; Karahan AY
    Acta Medica (Hradec Kralove); 2014; 57(3):97-104. PubMed ID: 25649364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute colchicine intoxication--possible role of erythromycin administration.
    Caraco Y; Putterman C; Rahamimov R; Ben-Chetrit E
    J Rheumatol; 1992 Mar; 19(3):494-6. PubMed ID: 1578471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial Mediterranean fever and amyloidosis.
    Kidney Int; 1981 Nov; 20(5):676-85. PubMed ID: 7343715
    [No Abstract]   [Full Text] [Related]  

  • 31. Necrotizing crescentic glomerulonephritis with granulomatous vasculitis in a patient with familial Mediterranean fever and renal amyloidosis.
    Cefle A; Kilicaslan I; Gul A; Kamali S; Inanc M; Konice M
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):80. PubMed ID: 15515794
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chronic human colchicine myopathy].
    Iwatsubo T; Ishige Y; Nukina N; Mannen T
    Rinsho Shinkeigaku; 1990 Sep; 30(9):1001-4. PubMed ID: 2265497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
    Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of colchicine on the amyloidosis of familial Mediterranean fever].
    Zemer D; Sohar E; Pras M; Cabili S; Gafni J
    Harefuah; 1985 Jan; 108(1):1-2. PubMed ID: 3996948
    [No Abstract]   [Full Text] [Related]  

  • 35. [Familial Mediterranean fever: not to be missed].
    Frenkel J; Bemelman FJ; Potter van Loon BJ; Simon A
    Ned Tijdschr Geneeskd; 2013; 157(18):A5784. PubMed ID: 23635502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regression of nephrotic syndrome due to amyloidosis secondary to familial mediterranean fever following colchicine treatment.
    Simşek B; Işlek I; Simşek T; Küçüködük S; Cengiz K
    Nephrol Dial Transplant; 2000 Feb; 15(2):281-2. PubMed ID: 10648685
    [No Abstract]   [Full Text] [Related]  

  • 37. Colchicine in the treatment of AA and AL amyloidosis.
    Livneh A; Zemer D; Langevitz P; Shemer J; Sohar E; Pras M
    Semin Arthritis Rheum; 1993 Dec; 23(3):206-14. PubMed ID: 8122124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.
    Zemer D; Pras M; Sohar E; Modan M; Cabili S; Gafni J
    N Engl J Med; 1986 Apr; 314(16):1001-5. PubMed ID: 3515182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever.
    Hamanoue S; Suwabe T; Hoshino J; Sumida K; Mise K; Hayami N; Sawa N; Takaichi K; Fujii T; Ohashi K; Yazaki M; Ikeda S; Ubara Y
    Mod Rheumatol; 2016 Jul; 26(4):610-3. PubMed ID: 25619282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic familial Mediterranean fever with development of secondary amyloidosis.
    Larrimore C
    Clin Lab Sci; 2011; 24(1):2-7. PubMed ID: 21404957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.